Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg’.
The above information is a part of company’s filings submitted to BSE.